Tobacco Use Disorder
Adolescents are increasingly using e-cigarette products such as pod-based systems but have misperceptions and lack of knowledge about these products.
"Pod mods," which are small, rechargeable devices that aerosolize liquid solutions containing nicotine encapsulated in cartridges, pose a danger to adolescent users.
Future public health interventions developed for cigarette use must accommodate individuals with mental health and substance use disorders.
Calling the use of electronic cigarettes a burgeoning epidemic among teens, the FDA announced a crackdown on the sale of Juuls and other flavored e-cigarette devices to minors.
Nationwide initiatives to decrease cigarette smoking prevalence have not accommodated individuals with mental health or substance use disorders.
Non-smoking adolescents with tobacco smoke exposure have increased risk for TSE-related symptoms.
Teenagers' use of any tobacco products, including electronic cigarettes, is associated with subsequent marijuana use.
The AMA has adopted several policies to improve the regulation of tobacco products, including electronic cigarettes.
There was a large increase in sales of electronic cigarettes and related products in the United States in recent years as their prices fell.
Electronic cigarette use is most common among current smokers.
There have been substantial increases in complete abstinence from substance use reported by high school students over the past 40 years.
Misleading portrayals of tobacco's health consequences in popular YouTube videos can increase positivity toward featured products including hookahs and e-cigarettes.
Some individuals self-report that electronic cigarettes help them quit smoking conventional cigarettes.
Youth should be protected from electronic cigarettes and other nicotine delivery devices.
Flavoring additives used in electronic cigarettes may have adverse effects on blood vessels.
Nicotine preloading does not significantly increase subsequent smoking abstinence in adult daily smokers with tobacco dependence.
Financial incentives added to free cessation aids can improve the rate of sustained abstinence among smokers.
AAFP and other signatories also call on FDA to apply the proposal to other combustible tobacco products.
Youth with asthma have considerably higher use of tobacco products than those without asthma.
From 2011 to 2017 there were decreases in current use of any tobacco products among high and middle school students.
Researchers emphasized the necessity of developing targeted interventions to address such health disparities among American Indian communities.
UK National Health Service Explores Justification for Rationing Elective Surgery in Smokers, ObesityJune 08, 2018
Recent measures in the United Kingdom have proposed restricting access to elective surgery for smokers and people with obesity.
CDC Report: Integrating Tobacco Cessation Interventions in Mental Health, Substance Abuse Treatment FacilitiesJune 05, 2018
Providing barrier-free access to proven cessation treatments is critical to reduce smoking-related disease and death in the United States.
Researchers proposed that future projects investigate the geographical and temporal trends in substance use and its disease burden.
There were no observable differences in the incidence of any cardiovascular events across the smoking cessation treatment groups.
Mortality rates decreased for alcohol use disorders, self-harm, and interpersonal violence between 1980 and 2014. Mortality rates for drug use disorders increased both nationally and in each county over the same period.
The findings of these analyses suggest that, to an extent, this relationship might be generalized to cannabis users as a whole, not just those diagnosed with a cannabis use disorder.
The more chemicals in e-liquid, the more toxic it is likely to be.
E-cigarettes are associated with more harm than good on a population level.
Most adolescent users of tobacco products do not identify as users.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- The Challenges of Identifying Biomarkers of Psychiatric Illness
- FDA Approves Powerful New Opioid Despite Criticisms
- Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation
- Insomnia in Borderline Personality Disorder May Increase Suicide Risk
- FDA to Ban Most Flavored Electronic Cigarettes
- Predictors of CBT Outcomes Identified in Youths With Anxiety Disorders
- Happy Childhood Memories Associated With Better Health
- FDA Launches MyStudies Mobile App in Effort to Increase Access to Real World Patient Data
- Heart Rate Variability Predicts Treatment Response in Anxious Depression